NEW YORK–(BUSINESS WIRE)–Faruqi & Faruqi, LLP, a leading national securities law firm, reminds
investors in OPKO Health, Inc. (“OPKO” or the “Company”) (NASDAQ:OPK) of
the November 13, 2018 deadline to seek the role of lead plaintiff in a
federal securities class action that has been filed against the Company.
If you invested in OPKO Health, Inc. stock or options between
September 26, 2013 and September 7, 2018 and would like to discuss
your legal rights, click here:
There is no cost or obligation to you.
You can also contact us by calling Richard Gonnello toll free at
877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com.
The lawsuit has been filed in the U.S. District Court for the District
of New Jersey on behalf of all those who purchased OPKO securities
between September 26, 2013 and September 7, 2018 (the “Class Period”).
The case, Kerznowski v. OPKO Health, Inc. et al, No. 18-cv-13834
was filed on September 12, 2018 and has been assigned to Stanley R.
The lawsuit focuses on whether the Company and its executives violated
federal securities laws by failing to disclose that: (1) Defendant Frost
and OPKO were engaged in a pump-and-dump scheme with several other
individuals and companies in their investments in several penny stocks;
and (2) this illicit scheme would result in governmental scrutiny
including from the SEC.
Specifically, on September 7, 2018, the SEC issued a press release
entitled ‘SEC Charges Microcap Fraudsters for Roles in Lucrative Market
On this news, the Company’s share price fell from $5.58 per share on
September 6, 2018 to $4.58 per share on September 7, 2018—a $1.01 or
The court-appointed lead plaintiff is the investor with the largest
financial interest in the relief sought by the class who is adequate and
typical of class members who directs and oversees the litigation on
behalf of the putative class. Any member of the putative class may move
the Court to serve as lead plaintiff through counsel of their choice, or
may choose to do nothing and remain an absent class member. Your ability
to share in any recovery is not affected by the decision to serve as a
lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding
OPKO’s conduct to contact the firm, including whistleblowers, former
employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is
Faruqi & Faruqi, LLP (www.faruqilaw.com).
Prior results do not guarantee or predict a similar outcome with respect
to any future matter. We welcome the opportunity to discuss your
particular case. All communications will be treated in a confidential
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
York, NY 10017
Attn: Richard Gonnello, Esq.
(877) 247-4292 or (212) 983-9330